Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute & South African MRC/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa.
Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, Cape Town, South Africa.
Int J Infect Dis. 2020 Jul;96:240-243. doi: 10.1016/j.ijid.2020.04.053. Epub 2020 Apr 24.
Between-person variability in T-cell-specific interferon-gamma release assay (IGRA) responses and discordance between IGRA test formats are poorly understood.
We evaluated the IFN-γ responses (QuantiFERON-TB Gold-In-Tube [QFT-GIT] and TSPOT-TB) stratified according to the Mycobacterium tuberculosis spoligotype of the culture isolate obtained from the same patients with confirmed active tuberculosis (n = 91). We further analysed differences within the RD-1-encoding ESX-1 region between the different strain types using whole genome sequencing.
In HIV-uninfected patients, TSPOT.TB and QFT-GIT IFN-γ responses were 5-fold (p < 0.01) and 2-fold higher (p < 0.05) for those infected with family 33 compared to the LAM strain (additionally, TSPOT.TB responses were 5.6-fold [p < 0.05] and 2.6-fold higher [p < 0.05] for the patients infected with the family 33 versus the X strain and Beijing versus the LAM strain, respectively). Multivariate analysis revealed that strain type (determined by spoligotyping) was independently associated with the magnitude of the IGRA response (varied by IGRA test type) and this is likely explained by variability in the ESX-1 region of Mycobacteriumtuberculosis (determined by next-generation sequencing).
These data have implications for the understanding of between-person heterogeneity in IGRA responses, Mycobateriumtuberculosis-specific host immunity, and the discordance between different IGRA test formats.
个体间 T 细胞特异性干扰素 -γ 释放试验(IGRA)反应的变异性和 IGRA 检测方法之间的不匹配程度尚未得到充分理解。
我们根据从同一确诊活动性肺结核患者中获得的培养物的结核分枝杆菌 spoligotype 对 IFN-γ 反应(QuantiFERON-TB Gold-In-Tube [QFT-GIT] 和 TSPOT-TB)进行分层。我们还使用全基因组测序分析了不同菌株类型之间 RD-1 编码 ESX-1 区域内的差异。
在未感染 HIV 的患者中,与 LAM 株相比,家族 33 感染患者的 TSPOT.TB 和 QFT-GIT IFN-γ 反应分别高出 5 倍(p < 0.01)和 2 倍(p < 0.05)(此外,与 X 株相比,家族 33 感染患者的 TSPOT.TB 反应高出 5.6 倍(p < 0.05)和 2.6 倍(p < 0.05),与 LAM 株相比,北京株高出 2.6 倍(p < 0.05))。多变量分析显示,菌株类型(通过 spoligotyping 确定)与 IGRA 反应的幅度(因 IGRA 检测类型而异)独立相关,这可能与结核分枝杆菌 ESX-1 区域的变异性(通过下一代测序确定)有关。
这些数据对理解 IGRA 反应的个体间异质性、结核分枝杆菌特异性宿主免疫以及不同 IGRA 检测方法之间的不匹配程度具有重要意义。